一种基于黄金的氧化酸化抑制剂对三阴性乳腺癌有效
R Tyler Mertens1, Jong Hyun Kim1, Samuel Ofori2
1Department of Chemistry, University of Kentucky; Lexington, KY 40506, United States.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|December 21, 2023
概括
一种新的黄金化合物 (AuDTC) 通过破坏癌细胞代谢和线粒体,有效向三阴性乳腺癌 (TNBC). 这种代谢向方法显示了TNBC治疗的治疗潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 三重阴性乳腺癌 (TNBC) 由于代谢异质性和有限的治疗选择,提出了重大挑战.
- 准癌细胞代谢是开发新TNBC治疗的有希望的策略.
- 有机金属金 (III) 化合物在调节细胞呼吸方面表现出潜力.
研究的目的:
- 为了研究一种金(III) 滴氧碳酸盐 (AuDTC) 化合物在向TNBC时的疗效.
- 确定AuDTC是否可以调节线粒体功能并诱导癌细胞的氧化损伤.
- 在临床前TNBC模型中评估AuDTC的治疗潜力.
主要方法:
- 设计和合成有机金属Au (III) 化合物.
- 在体外评估AuDTC对癌细胞线粒体和氧化应激的影响.
- 在TNBC小鼠模型中对AuDTC疗效的体内评估,具有不同的代谢概况.
主要成果:
- auDTC化合物有效地诱导了癌细胞中的线粒体功能障碍和氧化损伤.
- 在TNBC小鼠模型中,AuDTC显示出有效性,特别是那些依赖氧化酸化的小鼠模型.
- 在已建立的TNBC模型中,AuDTC的系统输送显示了治疗潜力.
结论:
- AuDTC是一种有效的线粒体呼吸调节器,对TNBC具有显著的抗癌活性.
- 准代谢途径,特别是线粒体呼吸,是TNBC的可行的治疗策略.
- AuDTC为治疗三阴性乳腺癌提供了进一步的临床开发.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Electron Transport Chain: Complex I and II
13.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.7K


